Cargando…
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
PURPOSE: Cutaneous melanoma is among the fastest growing malignancies in Norway and ultraviolet radiation (UVR) exposure is the primary environmental risk factor. Immunomodulating drugs can increase skin photosensitivity and suppress immune responses, and by such mechanisms influence melanoma risk....
Autores principales: | Berge, Leon Alexander Mclaren, Andreassen, Bettina Kulle, Stenehjem, Jo Steinson, Heir, Trond, Karlstad, Øystein, Juzeniene, Asta, Ghiasvand, Reza, Larsen, Inger Kristin, Green, Adele C, Veierød, Marit Bragelien, Robsahm, Trude Eid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755337/ https://www.ncbi.nlm.nih.gov/pubmed/33376408 http://dx.doi.org/10.2147/CLEP.S269446 |
Ejemplares similares
-
Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case–control study
por: Berge, Leon Alexander Mclaren, et al.
Publicado: (2019) -
Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study
por: Ghiasvand, Reza, et al.
Publicado: (2022) -
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
por: Berge, Leon Alexander Mclaren, et al.
Publicado: (2020) -
A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival
por: Stenehjem, Jo Steinson, et al.
Publicado: (2017) -
Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study
por: Gislefoss, Randi Elin, et al.
Publicado: (2018)